These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 19847802)

  • 1. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis.
    Kuhn NZ; Tuan RS
    J Cell Physiol; 2010 Feb; 222(2):268-77. PubMed ID: 19847802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multifaceted role of periostin in priming the tumor microenvironments for tumor progression.
    Cui D; Huang Z; Liu Y; Ouyang G
    Cell Mol Life Sci; 2017 Dec; 74(23):4287-4291. PubMed ID: 28884337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow-derived mesenchymal stem cells undergo JCV T-antigen mediated transformation and generate tumors with neuroectodermal characteristics.
    Del Valle L; Piña-Oviedo S; Perez-Liz G; Augelli BJ; Azizi SA; Khalili K; Gordon J; Krynska B
    Cancer Biol Ther; 2010 Feb; 9(4):286-94. PubMed ID: 20190567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cells in tissues, organoids, and cancers.
    Wang X
    Cell Mol Life Sci; 2019 Oct; 76(20):4043-4070. PubMed ID: 31317205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracrine signaling between carcinoma cells and mesenchymal stem cells generates cancer stem cell niche via epithelial-mesenchymal transition.
    Räsänen K; Herlyn M
    Cancer Discov; 2012 Sep; 2(9):775-7. PubMed ID: 22969117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model of cancer stem cell driven tumor initiation: implications of niche size and loss of homeostatic regulatory mechanisms.
    Gentry SN; Jackson TL
    PLoS One; 2013; 8(8):e71128. PubMed ID: 23990931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why are MSCs therapeutic? New data: new insight.
    Caplan AI
    J Pathol; 2009 Jan; 217(2):318-24. PubMed ID: 19023885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation Mechanisms and Maintenance Strategies of Stemness in Mesenchymal Stem Cells.
    Jiang N; Tian X; Wang Q; Hao J; Jiang J; Wang H
    Stem Cell Rev Rep; 2024 Feb; 20(2):455-483. PubMed ID: 38010581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the stem cell origin of cancer.
    Sell S
    Am J Pathol; 2010 Jun; 176(6):2584-494. PubMed ID: 20431026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of undifferentiated cancer cells by pluripotent stem cell inhibitors.
    Ben-David U; Biran A; Scaffidi P; Herold-Mende C; Boehringer M; Meshorer E; Benvenisty N
    J Mol Cell Biol; 2014 Jun; 6(3):267-9. PubMed ID: 24683201
    [No Abstract]   [Full Text] [Related]  

  • 11. Metastasis-Initiating Cells and Ecosystems.
    Massagué J; Ganesh K
    Cancer Discov; 2021 Apr; 11(4):971-994. PubMed ID: 33811127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment.
    Aponte PM; Caicedo A
    Stem Cells Int; 2017; 2017():5619472. PubMed ID: 28473858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenesis and cancer stem cells: current opinions and future directions.
    Cheng X; O'Neill HC
    J Cell Mol Med; 2009; 13(11-12):4377-84. PubMed ID: 19175465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype.
    Gerlee P; Anderson AR
    J Theor Biol; 2008 Feb; 250(4):705-22. PubMed ID: 18068192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing stemness in T cell differentiation.
    Henning AN; Klebanoff CA; Restifo NP
    Science; 2018 Jan; 359(6372):163-164. PubMed ID: 29326263
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial for the Special Issue "Latest Review Papers in Molecular Oncology 2023".
    Stolfi C
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells maintain long-term in vitro stemness during explant culture.
    Otte A; Bucan V; Reimers K; Hass R
    Tissue Eng Part C Methods; 2013 Dec; 19(12):937-48. PubMed ID: 23560527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche.
    Birmingham E; Niebur GL; McHugh PE; Shaw G; Barry FP; McNamara LM
    Eur Cell Mater; 2012 Jan; 23():13-27. PubMed ID: 22241610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of pluripotency in vivo and in vitro.
    Posfai E; Tam OH; Rossant J
    Curr Top Dev Biol; 2014; 107():1-37. PubMed ID: 24439801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis.
    Boomsma RA; Geenen DL
    PLoS One; 2012; 7(4):e35685. PubMed ID: 22558198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.